Clinical trial
SUPPORTIVE-EXPRESSIVE GROUP THERAPY FOR MEN WITH PRIMARY PROSTATE CANCER
NCT00002848 is registered in ClinicalTrials.gov with Gary Morrow as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SUPPORTIVE-EXPRESSIVE GROUP THERAPY FOR MEN WITH PRIMARY PROSTATE CANCER
- Lead sponsor
- Gary Morrow
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 1997
- Completion date
- September 30, 2004
- Enrollment
- 480 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer, psychosocial effects of cancer and its treatment